Autoinduction of Retinoic Acid Metabolism to Polar Derivatives with Decreased Biological Activity in Retinoic Acid-sensitive, but Not in Retinoic Acid-resistant Human Breast Cancer Cells
Open Access
- 1 July 1997
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 272 (29) , 17921-17928
- https://doi.org/10.1074/jbc.272.29.17921
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Adjuvant treatment of stage I lung cancer with high-dose vitamin A.Journal of Clinical Oncology, 1993
- Variability in the Oral Bioavailability of All-trans-Retinoic AcidJNCI Journal of the National Cancer Institute, 1993
- 13-cis-Retinoic Acid Plus Interferon -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the CervixJNCI Journal of the National Cancer Institute, 1992
- 13-cis-Retinoic Acid and Interferon -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the SkinJNCI Journal of the National Cancer Institute, 1992
- 9-cis retinoic acid is a high affinity ligand for the retinoid X receptorCell, 1992
- 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRαNature, 1992
- All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results [see comments]Blood, 1990
- Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 1990
- Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemiaBlood, 1988
- 13-cis-Retinoic Acid in the Treatment of Oral LeukoplakiaNew England Journal of Medicine, 1986